NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Fastly, Inc. (NYSE:FSLY)
CONTACT JAKUBOWITZ ABOUT FSLY:
https://claimyourloss.com/securities/fastly-inc-loss-submission-form/?id=10393&from=1
Class Period : May 6, 2020 - August 5, 2020
Lead Plaintiff Deadline : October 26, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Fastly's largest customer was ByteDance, operator of TikTok, which was known to have serious security risks and was under intense scrutiny by U.S. officials; (2) there was a material risk that Fastly's business would be adversely impacted should any adverse actions be taken against ByteDance or TikTok by the U.S. government; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Loop Industries, Inc. (NASDAQ:LOOP)
CONTACT JAKUBOWITZ ABOUT LOOP:
https://claimyourloss.com/securities/loop-industries-inc-loss-submission-form/?id=10393&from=1
Class Period : September 24, 2018 - October 12, 2020
Lead Plaintiff Deadline : December 14, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Loop scientists were encouraged to misrepresent the results of Loop's purportedly proprietary process; (2) Loop did not have the technology to break PET down to its base chemicals at a recovery rate of 100%; (3) as a result, the Company was unlikely to realize the purported benefits of Loop's announced partnerships with Indorama Ventures Public Company Limited and thyssenkrupp Industrial Solutions; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA)
CONTACT JAKUBOWITZ ABOUT RETA:
https://claimyourloss.com/securities/reata-pharmaceuticals-inc-loss-submission-form/?id=10393&from=1
Class Period : October 15, 2019 - August 7, 2020
Lead Plaintiff Deadline : December 14, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the MOXIe Part 2 study results were insufficient to support a single study marketing approval of omaveloxolone for the treatment of FA in the U.S. without additional evidence; (ii) as a result, it was foreseeable that the FDA would not accept marketing approval of omaveloxolone for the treatment of FA in the U.S. based on the MOXIe Part 2 study results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Jakubowitz Law
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law